Skip to content
PTCT·Nasdaq·US

PTC Therapeutics

PTC Therapeutics is a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders, with a diversified portfolio of commercial products and product candidates addressing rare diseases in neurology and metabolism.

Source: SEC 10-K Feb 19, 2026

Thematic Position

PTCT

Relationship Groups

Partners2
Licensing2
Competitors24

Relationship details are part of the Pro plan.

Recent Discoveries

Recent discoveries are part of the Pro plan.

Ended Relationships

9 ended relationships · Ended relationships are part of the Pro plan.

Management Perspective on Regulatory & Geopolitical Developments

government rightsmarch-in rightsIP restriction
U.S. government march-in rights on federally funded patented technology
SEC 10-KFeb 19, 2026

The full regulatory passage is part of the Pro plan.

24 more · Regulatory and geopolitical insights are part of the Pro plan.